Modern approaches of effective prevention of NSAIDs-gastropathy

The aim of review. To present current approach for NSAIDs-gastropathy prevention.Summary. Upper gastrointestinal lesions, related to intake of nonsteroid anti-inflammatory drugs (NSAIDs) represent a serious social and medical problem. This is related to increase in NSAIDs and low dozes of aspirin us...

Full description

Saved in:
Bibliographic Details
Main Author: A. Ye. Karateyev
Format: Article
Language:Russian
Published: Gastro LLC 2015-12-01
Series:Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:
Online Access:https://www.gastro-j.ru/jour/article/view/1044
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823860122936410112
author A. Ye. Karateyev
author_facet A. Ye. Karateyev
author_sort A. Ye. Karateyev
collection DOAJ
description The aim of review. To present current approach for NSAIDs-gastropathy prevention.Summary. Upper gastrointestinal lesions, related to intake of nonsteroid anti-inflammatory drugs (NSAIDs) represent a serious social and medical problem. This is related to increase in NSAIDs and low dozes of aspirin users number, who are mostly elderly people, often having combination of several diseases with serious risk of drug-induced complications. Even after safer class of NSAIDs, i.e. selective cyclooxygenase-2 (COX-2) inhibitors were introduced to clinical practice and obvious successes in treatment of H. pylori-associated peptic ulcers, frequency of NSAIDs gastropathy still remains high. Besides that, NSAIDs gastropathy complications, such as bleeding and perforations, are accompanied by high mortality and serious treatment expenditures. This requires adequate prophylaxis of this pathology. Proton pump inhibitors (PPIs) play a special role as the main class of drugs used for NSAIDs gastropathy prevention at the present time. This review presents advantages of pantoprazole — a PPI, that possesses the minimal risk of unfavorable pharmacological interaction with drugs of other pharmacological classes.Conclusion. Application of less aggressive NSAIDs — selective COX-2 inhibitors and H. pylori eradication reduce risk of serious complications, but does not eliminate it completely. Therefore long-term PPI application is required for prevention of NSAID-related ulcers and gastro-intestinal bleeding in patients who receive NSAIDs on regular basis, in the case if they have risk factors for NSAIDs-gastropathy.
format Article
id doaj-art-41f5fa20b45f4dac8c7c5afcf2cbb325
institution Kabale University
issn 1382-4376
2658-6673
language Russian
publishDate 2015-12-01
publisher Gastro LLC
record_format Article
series Российский журнал гастроэнтерологии, гепатологии, колопроктологии
spelling doaj-art-41f5fa20b45f4dac8c7c5afcf2cbb3252025-02-10T16:14:34ZrusGastro LLCРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии1382-43762658-66732015-12-0125692102650Modern approaches of effective prevention of NSAIDs-gastropathyA. Ye. Karateyev0Federal State Budget Scientific Institution «Nasonova scientific research institute of rheumatology»The aim of review. To present current approach for NSAIDs-gastropathy prevention.Summary. Upper gastrointestinal lesions, related to intake of nonsteroid anti-inflammatory drugs (NSAIDs) represent a serious social and medical problem. This is related to increase in NSAIDs and low dozes of aspirin users number, who are mostly elderly people, often having combination of several diseases with serious risk of drug-induced complications. Even after safer class of NSAIDs, i.e. selective cyclooxygenase-2 (COX-2) inhibitors were introduced to clinical practice and obvious successes in treatment of H. pylori-associated peptic ulcers, frequency of NSAIDs gastropathy still remains high. Besides that, NSAIDs gastropathy complications, such as bleeding and perforations, are accompanied by high mortality and serious treatment expenditures. This requires adequate prophylaxis of this pathology. Proton pump inhibitors (PPIs) play a special role as the main class of drugs used for NSAIDs gastropathy prevention at the present time. This review presents advantages of pantoprazole — a PPI, that possesses the minimal risk of unfavorable pharmacological interaction with drugs of other pharmacological classes.Conclusion. Application of less aggressive NSAIDs — selective COX-2 inhibitors and H. pylori eradication reduce risk of serious complications, but does not eliminate it completely. Therefore long-term PPI application is required for prevention of NSAID-related ulcers and gastro-intestinal bleeding in patients who receive NSAIDs on regular basis, in the case if they have risk factors for NSAIDs-gastropathy.https://www.gastro-j.ru/jour/article/view/1044nsaids-gastropathygastro-intestinal bleedingpreventionh. pylorippipantoprazole
spellingShingle A. Ye. Karateyev
Modern approaches of effective prevention of NSAIDs-gastropathy
Российский журнал гастроэнтерологии, гепатологии, колопроктологии
nsaids-gastropathy
gastro-intestinal bleeding
prevention
h. pylori
ppi
pantoprazole
title Modern approaches of effective prevention of NSAIDs-gastropathy
title_full Modern approaches of effective prevention of NSAIDs-gastropathy
title_fullStr Modern approaches of effective prevention of NSAIDs-gastropathy
title_full_unstemmed Modern approaches of effective prevention of NSAIDs-gastropathy
title_short Modern approaches of effective prevention of NSAIDs-gastropathy
title_sort modern approaches of effective prevention of nsaids gastropathy
topic nsaids-gastropathy
gastro-intestinal bleeding
prevention
h. pylori
ppi
pantoprazole
url https://www.gastro-j.ru/jour/article/view/1044
work_keys_str_mv AT ayekarateyev modernapproachesofeffectivepreventionofnsaidsgastropathy